Relative to Alzheimer’s and Brain Awareness Month and The Longest Day.
The resolution is noteworthy as it addresses significant demographic shifts, indicating that the number of Californians living with Alzheimer’s is expected to increase by 127% over the next 20 years, particularly affecting communities of color. The bill highlights the urgency for more comprehensive research funding and community support systems for caregivers, who currently contribute the equivalent of over $18 billion in unpaid care. By establishing a dedicated month, the resolution aims to foster a sense of solidarity and support for families impacted by the disease, reinforcing California's commitment to public health education and resources.
Senate Resolution 90, introduced by Senator Durazo, designates June 2022 as Alzheimer's and Brain Awareness Month in California. The resolution aims to raise awareness about Alzheimer's disease and emphasizes the need for public education on the economic and personal costs of this debilitating condition. It aligns with the observance of The Longest Day on June 21, 2022, which encourages community engagement through activities that honor those affected by Alzheimer's. The high prevalence of Alzheimer’s in California, currently estimated at 690,000 residents, underscores the importance of this resolution in mobilizing public support and resources.
The sentiment surrounding SR90 is predominantly positive, reflecting a collective understanding of the challenges posed by Alzheimer's disease within the community. Advocates believe that by increasing awareness, the state can better address the needs of individuals living with Alzheimer's and their caregivers. The framing of the resolution as supportive and community-oriented has received broad bipartisan support, as evidenced by the unanimous passage through the Senate, signifying a collective recognition of the importance of tackling Alzheimer's on a societal level.
While the bill itself is non-controversial, it does spotlight underlying issues related to health disparities and the need for tailored interventions for at-risk populations. Critics may argue that mere declarations are insufficient without actionable policy changes and funding commitments to mitigate the anticipated surge in Alzheimer's cases. Nonetheless, SR90 serves primarily as a vehicle for raising recognition and mobilizing advocacy efforts rather than as a source of legislative contention.